| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Department of Veterans Affairs |
| Information provided by: | Department of Veterans Affairs |
| ClinicalTrials.gov Identifier: | NCT00011323 |
Purpose
The goals of this project are to establish a new cohort of male veterans and describe associations between potential risk factors and baseline bone mineral density (BMD) as well as rates of BMD loss.
| Condition |
|
Osteoporosis |
| MedlinePlus related topics: | Caffeine Osteoporosis Smoking |
| Drug Information available for: | Ethanol 3,7-Dihydro-1,3,7-trimethyl-1H-purine-2,6-dione Caffeine citrate |
| Study Type: | Observational |
| Study Design: | Natural History, Convenience Sample |
| Official Title: | Prevalence and Determinants of Osteoporosis in Male Veterans |
| Estimated Enrollment: | 1000 |
| Study Start Date: | June 1998 |
| Estimated Study Completion Date: | January 2001 |
 |
Show Detailed Description |
Eligibility
| Ages Eligible for Study: | 50 Years and older |
| Genders Eligible for Study: | Male |
| Accepts Healthy Volunteers: | No |
Veterans aged 50 and older drawn from two existing VA cohorts, the Normative Aging Study (NAS) and the Veterans Health Study (VHS).
Contacts and Locations More Information
| Study ID Numbers: | 714B |
| First Received: | February 15, 2001 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00011323 |
| Health Authority: | United States: Federal Government |
|
|
|
|
